Gossamer Bio, Inc.
GOSS
$0.16
-$0.02-11.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 144.16% | -27.37% | -43.02% | -56.55% | -177.74% |
| Total Depreciation and Amortization | 18.31% | -32.16% | -78.88% | -79.96% | -78.53% |
| Total Amortization of Deferred Charges | 1,922.45% | 5.81% | 5.46% | 5.98% | -23.68% |
| Total Other Non-Cash Items | -7,497.20% | 2,254.20% | 1.34% | 474.68% | -68.03% |
| Change in Net Operating Assets | -42.00% | 153.18% | 39.40% | 174.77% | -115.50% |
| Cash from Operations | 16.23% | 2.52% | -36.17% | -12.91% | -140.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.35% | 88.36% | 37.47% | 163.59% | 174.74% |
| Cash from Investing | -3.23% | 88.59% | 37.47% | 163.59% | 174.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 1.59% | -- | 566.19% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,444.68% | 1.59% | -- | 566.19% | 101.02% |
| Foreign Exchange rate Adjustments | -109.30% | -196.19% | 101.60% | -202.15% | 1,712.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.42% | 119.33% | 63.54% | 70.25% | -105.65% |